Nonoperative Management or ‘Watch and Wait’ for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal

被引:0
作者
Tarik Sammour
Brandee A. Price
Kate J. Krause
George J. Chang
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[2] The University of Texas MD Anderson Cancer Center,Research Medical Library
[3] The University of Texas MD Anderson Cancer Center,Department of Health Services Research
来源
Annals of Surgical Oncology | 2017年 / 24卷
关键词
Complete Clinical Response; Rectal Cancer; Surgical Salvage; Surgical Control Group; Radical Proctectomy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1904 / 1915
页数:11
相关论文
共 85 条
[1]  
Tural D(2013)The relation between pathological complete response and clinical outcome in patients with rectal cancer Hepatogastroenterology. 60 1365-1370
[2]  
Selcukbiricik F(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol. 30 1770-1776
[3]  
Ozturk MA(2016)Complete clinical response in rectal cancer: a turning tide Lancet Oncol. 17 125-126
[4]  
Park IJ(2009)Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis Dis Colon Rectum. 52 863-871
[5]  
You YN(2013)Rectal cancer: is ‘watch and wait’ a safe option for rectal cancer? Nat Rev Gastroenterol Hepatol. 10 698-700
[6]  
Agarwal A(2011)Current concepts in the non-operative management of rectal cancer after neoadjuvant chemoradiation Anticancer Res. 31 1795-1800
[7]  
Perez RO(2016)Complete response after chemoradiotherapy in rectal cancer (watch-and-wait): have we cracked the code? Clin Oncol. 28 152-160
[8]  
Neuman HB(2015)Simulating watch and wait for rectal cancer Dis Colon Rectum. 58 155-156
[9]  
Elkin EB(2015)Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model Dis Colon Rectum. 58 159-171
[10]  
Guillem JG(2009)PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med. 6 e1000097-927